Use of sapropterin in Mexican patients with yperphenylalaninemia

• Hoofdauteurs: Susana Monroy-Santoyo (Auteur), Leticia Belmont-Martínez (Auteur), Cynthia Fernández-Lainez (Auteur)
• Formaat: Boek
• Gepubliceerd in: Instituto Nacional de Pediatría, 2014-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Hyperphenylalaninemia is caused by deficient enzyme activity of phenylalanine hydroxylase. It was one of the first genetic disorders susceptible to treatment with a natural protein restricted diet for life. While this treatment has proven effective in preventing mental retardation, eliminating certa...